2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician NPI 1023472149 M.D.
Verify on CMS →

Poone Shoureshi, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician in Laguna Hills, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
755
Medicare Part D claims · 285 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician avg: 1K
Generic prescribing
62%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.9/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$1.8K
101 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Poone Shoureshi, M.D. reported a CMS MIPS final score of 98.9/100 — above the 83.1 national average — and filed 755 Medicare Part D claims in 2023.

98.9/100
MIPS score · +16 vs avg
755
Part D claims, 2023
62%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Poone Shoureshi, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

Poone Shoureshi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Poone Shoureshi, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/06/2016

NPI 1023472149

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician

Rare

109 US NPIs in this specialty

Medicare Part D claims

755 32% vs specialty avg

2023 prescription claims

Specialty avg: 1,103

MIPS final score

98.9/100 15.8 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician compares to other specialties among California providers

California providers

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician share within California

1. Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician share within California

Medicare quality performance — MIPS

Poone Shoureshi, M.D.'s 2023 MIPS final score plotted against the Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician national average

High performer (top quartile)
MIPS Final Score
98.9/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician) — 98.9/100 vs national avg 83.1

0%100%National avg83%98.9%
MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician) — 98.9/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Poone Shoureshi, M.D. appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider holding M.D. credentials at 23961 CALLE DE LA MAGDALENA STE 500, Laguna Hills, CA, 92653, with a listed phone of (949) 855-1101. NPI 1023472149 was issued on 04/06/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Shoureshi most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 755 prescription claims written by this provider, covering 285 Medicare beneficiaries and totaling roughly $217K in drug spend, split 38% brand-name and 62% generic by claim count, with an opioid prescribing rate of 1.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.9/100 for the 2023 performance year (Quality 97.7), compared with the national average of 83.1.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician is a narrow specialty nationwide, with 109 enrolled providers across 28 states and an average of 1,103 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

23961 CALLE DE LA MAGDALENA STE 500
Laguna Hills, CA 92653

Provider Details

NPI 1023472149
Specialty Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
Credentials M.D.
Gender Female
NPI Issued 04/06/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.8557
Final Score
Avg: 83.1
97.7114
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where Poone Shoureshi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Orange County Urology Associates Inc A Medical Group
Laguna Hills, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Poone Shoureshi, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.8K

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Poone Shoureshi, M.D.. To verify Poone Shoureshi, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Poone Shoureshi, M.D. — brand share 38.0%
Specialty average (est.)

38% brand-name claims vs 62% generic, on 755 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

755
Total Claims
$217K
Total Drug Cost
285
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,256
Total Day Supply
35,037
Brand vs Generic
38% brand / 62% generic
Brand Drug Cost
$179K
Generic Drug Cost
$38K
Opioid Claims
12 (1.6% rate)
Antibiotic Claims
87

Patient Demographics

Average Patient Age
77.0 years
Avg HCC Risk Score
1.44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Poone Shoureshi, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Estradiol
159
Gemtesa
Vibegron
125
Myrbetriq
Mirabegron
120
Methenamine Hippurate
89
Oxybutynin Chloride Er
Oxybutynin Chloride
31
Cephalexin
24
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
24
Trospium Chloride
18
Estring
Estradiol
15
Tamsulosin Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Overview

How Poone Shoureshi, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician landscape nationally.

109
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in US
28
States with Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician
1,103
Avg Claims per Provider

Poone Shoureshi, M.D.'s 755 claims are below the specialty average of 1,103.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Shoureshi.

Compare Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Poone Shoureshi, M.D.'s specialty?
Poone Shoureshi, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician and practices in Laguna Hills, California. Credentials: M.D..
How much does Poone Shoureshi, M.D. prescribe under Medicare Part D?
In 2023, Poone Shoureshi, M.D. wrote 755 Medicare Part D claims totaling $217K in drug costs for 285 beneficiaries.
What is Poone Shoureshi, M.D.'s Medicare quality score?
Poone Shoureshi, M.D. has a CMS MIPS Final Score of 98.9/100 (Quality: 97.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Poone Shoureshi, M.D. located?
Poone Shoureshi, M.D. is located at 23961 CALLE DE LA MAGDALENA STE 500, Laguna Hills, CA, 92653. Phone: (949) 855-1101.
What is Poone Shoureshi, M.D.'s NPI number?
Poone Shoureshi, M.D.'s National Provider Identifier (NPI) is 1023472149, issued on 04/06/2016.
Does Poone Shoureshi, M.D. prescribe more brand-name or generic drugs?
Poone Shoureshi, M.D.'s prescribing is 38% brand-name and 62% generic drugs by claim count, with $179K in brand drug costs.
Does Poone Shoureshi, M.D. prescribe opioids?
Yes, Poone Shoureshi, M.D. had 12 opioid claims in 2023 with an opioid prescribing rate of 1.6%.
How many Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers are there in the US?
There are 109 Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician providers across 28 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician provider writes 1,103 Medicare Part D claims per year.
What drugs does Poone Shoureshi, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Poone Shoureshi, M.D.'s most frequently prescribed drugs include Estradiol, Gemtesa, Myrbetriq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Poone Shoureshi, M.D. accept Medicare?
Poone Shoureshi, M.D. appears in CMS Medicare data with 755 Part D claims and 285 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Poone Shoureshi, M.D.'s credentials?
Poone Shoureshi, M.D.'s NPI is 1023472149 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology